BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36678151)

  • 1. Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance.
    Mráziková L; Hojná S; Vaculová P; Strnad Š; Vrkoslav V; Pelantová H; Kuzma M; Železná B; Kuneš J; Maletínská L
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
    Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
    Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.
    Čermáková M; Pelantová H; Neprašová B; Šedivá B; Maletínská L; Kuneš J; Tomášová P; Železná B; Kuzma M
    J Proteome Res; 2019 Apr; 18(4):1735-1750. PubMed ID: 30810318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.
    Mráziková L; Hojná S; Pačesová A; Hrubá L; Strnadová V; Neprašová B; Železná B; Kuneš J; Maletínská L
    Nutr Diabetes; 2022 May; 12(1):26. PubMed ID: 35589696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin-releasing peptide: a new tool for obesity treatment.
    Kuneš J; Pražienková V; Popelová A; Mikulášková B; Zemenová J; Maletínská L
    J Endocrinol; 2016 Aug; 230(2):R51-8. PubMed ID: 27418033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.
    Kořínková L; Holubová M; Neprašová B; Hrubá L; Pražienková V; Bencze M; Haluzík M; Kuneš J; Maletínská L; Železná B
    J Mol Endocrinol; 2020 Feb; 64(2):77-90. PubMed ID: 31855558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylated PrRP analog decreases body weight in DIO rats but not in ZDF rats.
    Holubová M; Zemenová J; Mikulášková B; Panajotova V; Stöhr J; Haluzík M; Kuneš J; Železná B; Maletínská L
    J Endocrinol; 2016 May; 229(2):85-96. PubMed ID: 26906745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.
    Maletínská L; Nagelová V; Tichá A; Zemenová J; Pirník Z; Holubová M; Špolcová A; Mikulášková B; Blechová M; Sýkora D; Lacinová Z; Haluzík M; Železná B; Kuneš J
    Int J Obes (Lond); 2015 Jun; 39(6):986-93. PubMed ID: 25771926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice.
    Pirník Z; Kolesárová M; Železná B; Maletínská L
    Neurochem Int; 2018 Jun; 116():77-84. PubMed ID: 29601847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.
    Prazienkova V; Ticha A; Blechova M; Spolcova A; Zelezna B; Maletinska L
    J Physiol Pharmacol; 2016 Feb; 67(1):121-8. PubMed ID: 27010901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells.
    Zmeškalová A; Popelová A; Exnerová A; Železná B; Kuneš J; Maletínská L
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
    Špolcová A; Mikulášková B; Holubová M; Nagelová V; Pirnik Z; Zemenová J; Haluzík M; Železná B; Galas MC; Maletínská L
    J Alzheimers Dis; 2015; 45(3):823-35. PubMed ID: 25624414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study.
    Mengr A; Hrubá L; Exnerová A; Holubová M; Popelová A; Železná B; Kuneš J; Maletínská L
    Curr Alzheimer Res; 2021; 18(8):607-622. PubMed ID: 34551697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.
    Mráziková L; Neprašová B; Mengr A; Popelová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
    Front Pharmacol; 2021; 12():779962. PubMed ID: 34867411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.
    Pirník Z; Kořínková L; Osacká J; Železná B; Kuneš J; Maletínská L
    Physiol Res; 2021 Aug; 70(4):579-590. PubMed ID: 34062082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats.
    Mikulášková B; Zemenová J; Pirník Z; Pražienková V; Bednárová L; Železná B; Maletínská L; Kuneš J
    Peptides; 2016 Jan; 75():109-17. PubMed ID: 26643957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Search for lipidized PrRP analogs with strong anorexigenic effect: In vitro and in vivo studies.
    Strnadová V; Karnošová A; Blechová M; Neprašová B; Holá L; Němcová A; Myšková A; Sýkora D; Železná B; Kuneš J; Maletínská L
    Neuropeptides; 2023 Apr; 98():102319. PubMed ID: 36669365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice.
    Pirnik Z; Železná B; Kiss A; Maletínská L
    Brain Res; 2015 Nov; 1625():151-8. PubMed ID: 26362395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study.
    Karnošová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.